GSK2636771 T2073
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GSK2636771, an effective, specific, orally bioavailable, PI3K_ inhibitor, has been used in cancer, lymphoma, solid neoplasm, recurrent solid neoplasm, and advanced malignant neoplasm.
CAS nr:
1372540-25-4
Purity:
98%
Molecular Weight:
433,42
SMILES:
c1(nc2c(n1Cc1c(c(ccc1)C(F)(F)F)C)cc(cc2C(=O)O)N1CCOCC1)C
Formula:
C22H22F3N3O3
Pathway:
PI3K/Akt/mTOR signaling
Target:
PI3K
